Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Furkan, Ceylan"'
Autor:
Cem ŞİMŞEK, Deniz Can GÜVEN, Furkan CEYLAN, İbrahim Yahya ÇAKIR, Taha Koray ŞAHİN, Ömer DİZDAR, Yasemin BALABAN, Şuayib YALÇIN
Publikováno v:
Journal of Oncological Sciences. 7:115-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8017619f0ffecc7ec59494049e50b8b1
https://doi.org/10.37047/jos.2021-84326
https://doi.org/10.37047/jos.2021-84326
Autor:
Furkan Ceylan, Deniz Can Guven, Hakan Taban, Oktay Aktepe, Taha Koray Sahin, Sadettin Kilickap, Alev Turker, Erhan Hamaloglu, Derya Karakoc, Aynur Isik, Aytekin Akyol, Suayib Yalcin, Omer Dizdar
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 47:102091
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e37150f11205c2769b62ceae69d64902
https://doi.org/10.1016/j.clinre.2023.102091
https://doi.org/10.1016/j.clinre.2023.102091
Autor:
Omer Dizdar, Burak Yasin Aktas, Mustafa Erman, Deniz Can Guven, Ezel Berker, Deniz Yuce, Furkan Ceylan, Abdullah C. Akman, Emre Yekedüz, Ilgın Akbiyik, Mutlu Hayran, Batuhan Baspinar
Publikováno v:
Turkish Journal of Medical Sciences
Volume: 49, Issue: 3 826-831
Volume: 49, Issue: 3 826-831
Background/aim: In this study, we aimed to assess the cancer risk among patients with periodontal disease.Materials and methods: Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 were included and data on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f407cd834779c0e349af9bf0c563f7fe
http://europepmc.org/articles/PMC7018248
http://europepmc.org/articles/PMC7018248
Autor:
Melek Seren Aksun, Zafer Arik, Sercan Aksoy, Neyran Kertmen, Taha Koray Sahin, Suayib Yalcin, Oktay Halit Aktepe, Omer Dizdar, Deniz Can Guven, Furkan Ceylan, Hasan Cagri Yildirim, Saadettin Kilickap, Hakan Taban, Mustafa Erman
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(9)
Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in cancer patients. However, the association of VTE with immunotherapy remains poorly defined. We therefore evaluated the frequency of VTE in patients receiving immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab7d9f339d7a25471a8076ec1beb3e0
https://pubmed.ncbi.nlm.nih.gov/33709186
https://pubmed.ncbi.nlm.nih.gov/33709186
Autor:
Irem Bilgetekin, Cihan Erol, Mehmet Ali Nahit Sendur, Ramazan Acar, Yuksel Urun, Naziyet Kose Baytemur, Emre Yekedüz, Mustafa Erman, Umut Demirci, Nuri Karadurmus, Saadettin Kilickap, Deniz Can Guven, Furkan Ceylan
Publikováno v:
Current problems in cancer. 45(6)
Background: Immunotherapy improves overall survival (OS) in the second and later lines of renal cell carcinoma (RCC) treatment. Recent studies have suggested that antibiotic (ATB) use either shortly before or after the start of immunotherapy could le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef03a162c4558982d4f05d11ae72abbd
https://pubmed.ncbi.nlm.nih.gov/34130864
https://pubmed.ncbi.nlm.nih.gov/34130864
Autor:
Zafer Arik, Omer Dizdar, Berkay Yesilyurt, Oktay Halit Aktepe, Gurkan Guner, Alev Turker, Deniz Can Guven, Basak Sayinalp, Ibrahim Yahya Cakir, Furkan Ceylan, Hasan Cagri Yildirim, Engin Cesmeci
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(7)
Unplanned readmission in the first 30 days after discharge is an important medical problem, although the data on cancer patients is limited. So we planned to evaluate the rates and causes of early readmissions and the predisposing factors. Patients h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d80c633d43a2f598e9e5c94c5940ef
https://pubmed.ncbi.nlm.nih.gov/33404804
https://pubmed.ncbi.nlm.nih.gov/33404804
Autor:
Umut Demirci, Nuri Karadurmus, Sadettin Kilickap, N. Kose Baytemur, Ramazan Acar, Yuksel Urun, Cihan Erol, Emre Yekedüz, Mehmet Ali Nahit Sendur, I. Bilgetekin, Deniz Can Guven, Furkan Ceylan, Mustafa Erman
Publikováno v:
Annals of Oncology. 31:S1457
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb4b9668d98839bce652ece42d92d576
https://doi.org/10.1016/j.annonc.2020.10.588
https://doi.org/10.1016/j.annonc.2020.10.588
Autor:
Deniz Can Guven, Hasan Cagri Yildirim, Furkan Ceylan, Saadettin Kilickap, Onur Bas, Omer Dizdar
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522096567
Introduction Although, immune check-point inhibitors changed the course of many cancers, the outcomes in sarcomas were rather disappointing with less than 10% response rates. Ewing sarcoma is a poorly differentiated and aggressive tumor mostly seen i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5adc0ba7cf658bf769d45696fb68aa9c
https://doi.org/10.1177/1078155220965677
https://doi.org/10.1177/1078155220965677
Autor:
Gurkan Guner, Hasan Cagri Yildirim, Zafer Arik, Alev Turker, Deniz Can Guven, Basak Sayinalp, Omer Dizdar, Berkay Yesilyurt, Furkan Ceylan, Engin Cesmeci, Ibrahim Yahya Cakir
Publikováno v:
Annals of Oncology. 31:S932
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f09fd7f9649cee9bad769354196088e
https://doi.org/10.1016/j.annonc.2020.08.131
https://doi.org/10.1016/j.annonc.2020.08.131
Autor:
Hakan Taban, Erhan Hamaloglu, Sadettin Kilickap, Deniz Can Guven, Oktay Halit Aktepe, Suayip Yalcin, Furkan Ceylan, Aynur Isik, Aytekin Akyol, Derya Karakoc, Alev Turker, Omer Dizdar
Publikováno v:
Annals of Oncology. 31:S947
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceca2a8c015f72e87ae1f97a409769d2
https://doi.org/10.1016/j.annonc.2020.08.2029
https://doi.org/10.1016/j.annonc.2020.08.2029